Egg banking for social reasons

Women feel positive about it, even though many believe they will never use the eggs they have stored

2013-07-09

(Press-News.org) London, 9 July 2013: Egg freezing as insurance against age-related infertility is a growing trend in many countries. Women who bank oocytes for use at some time in the future hope to buy a little time in their search for a suitable partner. However, a study from one of Europe's largest centres in reproductive medicine suggests that many of those banking eggs believe they will never use them - even though they still recognise the experience as "positive". The majority of those who did (and did not) freeze their eggs wished they had done so at an earlier age. The study of what is an increasingly common procedure was performed at the hospital of the Free University of Brussels, Belgium, and was presented at the annual meeting of ESHRE by Dr Dominic Stoop from the hospital's Centre for Reproductive Medicine. This was a study of what the investigators called "oocyte banking for anticipated gamete exhaustion", a term which reflects the motivation of participants and the biological certainty (the depletion of ovarian follicles over time) which the procedure hopes to overcome. The study was a follow-up survey of 140 women considering egg banking between 2009 and 2011. Their mean age was 37 years. They were surveyed with a questionnaire on their relational and reproductive circumstances, their attitude towards oocyte banking and their future reproductive plans. Of those surveyed, 86 women (61.4%) completed at least one treatment cycle from which eggs were collected and cryopreserved. The non-bankers included 54 women who either preferred no treatment (51%) or attempted stimulation but cancelled because of poor response (3%). Results showed that of those banking eggs around one-third (34.1%) believed they would never have to use them, with many (75%) indicating at follow-up that they considered the use of frozen oocytes less likely than anticipated at the time of oocyte collection. However, nearly all (96.2%) said they would do it again - but preferably (70.6%) at a younger age. Among those actually banking eggs, nearly all said they would recommend the treatment to others. The survey also showed that those banking eggs accepted a higher age for motherhood than those not doing so (43.8 years and 42,5 years) and all were still keen to have a baby. However, in terms of relationships and reproductive potential, there appeared little difference between the egg bankers and non-bankers, with similar steady relationships (around 50%), attempts at conception (around 35%) and experience of infertility (7%). The investigators thus suggest that oocyte freezing to preserve fertility provides important psychological reassurance for those opting to use the technology, as expressed by the positive response of all participants, even those with a lower intention of ever using their eggs. "Our results indicate that most women who have had oocyte cryopreservation have no regrets about it, but do wish they had done so at a younger age," said Dr Stoop. "This makes sense, because the younger the eggs, the better the chance of pregnancy. But ideally oocytes are cryopreserved in the early thirties, when oocyte quality is still good and we can retrieve a good number of oocytes per cycle. While oocyte quality and quantity are better at a younger age, women in their twenties still have a relatively long fertile period ahead of them, with a great chance that they may never need the cryopreserved oocytes." Dr Stoop added that, while oocyte cryopreservation has become a mainstream fertility technique with excellent results, especially in oocyte donation programmes, the clinical outcome of oocyte cryopreservation for anticipated gamete exhaustion at a more advanced maternal age is less certain. "Although the pioneer group in our study appears to be satisfied," he said, "a more efficient preservation of fertility would have required oocyte freezing at a significant younger age." Since 2009, about 140 women have had a minimum of one oocyte cryopreservation cycle at the Centre for Reproductive Medicine in Brussels. A total number of 2380 oocytes have been cryopreserved, with an average of 17 oocytes per woman (from an average of two cycles each). So far, only one woman has come back to thaw her oocytes (which were cryopreserved at the age of 39), but the embryo transfer did not result in pregnancy. ### Abstract 112, Tuesday 9 July 10.15 BST Oocyte banking for anticipated gamete exhaustion (AGE): a follow-up study Notes Oocyte banking has been revolutionised by a rapid freezing technique known as vitrification (which preserves cells in a glass-like state without the formation of ice crystals, which formerly proved damaging to the integrity of the egg). Recent studies suggest that oocytes warmed and fertilised after vitrification perform just as well in IVF as fresh oocytes. Oocyte vitrification for fertility preservation is currently performed for two different reason - for "medical indications", usually ahead of cancer treatment in younger women, and for social reasons (as is the case in this study), usually for biological clock reasons and as insurance against age-related infertility. When obtaining outside comment, journalists are requested to ensure that their contacts are aware of the embargo on this release. For further information on the details of this press release, contact: Christine Bauquis at ESHRE
Mobile: +32 (0)499 25 80 46
Email: christine@eshre.eu

ELSE PRESS RELEASES FROM THIS DATE:

Research demonstrates the influence of temporal niches in maintaining biodiversity

2013-07-09

By studying rapidly evolving bacteria as they diversify and compete under varying environmental conditions, researchers have shown that temporal niches are important to maintaining biodiversity in natural systems. The research is believed to be the first experimental demonstration of temporal niche dynamics promoting biodiversity over evolutionary time scales. The temporal niches – changes in environmental conditions that occur during specific periods of time – promoted frequency-dependent selection within the bacterial communities and positive growth of new mutants. ...

Tumor-suppressor Protein Gives Up Its Secrets

2013-07-09

Genetic mutations aren't the only thing that can keep a protein called PTEN from doing its tumor-suppressing job. Johns Hopkins researchers have now discovered that four small chemical tags attached (reversibly) to the protein's tail can have the same effect, and they say their finding may offer a novel path for drug design to keep PTEN working. In a report published on July 9 in the journal eLife, the Johns Hopkins scientists describe how a cluster of four phosphate groups, first found 13 years ago to bind to PTEN's tail, controls its activity. "Now that we know ...

What warring couples want: Power, not apologies, Baylor study shows

2013-07-09

The most common thing that couples want from each other during a conflict is not an apology, but a willingness to relinquish power, according to a new Baylor University study. Giving up power comes in many forms, among them giving a partner more independence, admitting faults, showing respect and being willing to compromise. The study is published in the Journal of Social and Clinical Psychology. "It's common for partners to be sensitive to how to share power and control when making decisions in their relationship," said researcher Keith Sanford, Ph.D., an associate professor ...

Scientists image vast subglacial water system under West Antarctica's Thwaites Glacier

2013-07-09

AUSTIN, Texas — In a development that will help predict potential sea level rise from the Antarctic ice sheet, scientists from The University of Texas at Austin's Institute for Geophysics have used an innovation in radar analysis to accurately image the vast subglacial water system under West Antarctica's Thwaites Glacier. They have detected a swamp-like canal system beneath the ice that is several times as large as Florida's Everglades. The findings, as described this week in the Proceedings of the National Academy of Sciences, use new observational techniques to address ...

Bird vaccine for West Nile Virus

2013-07-09

University of British Columbia researchers have developed a vaccine that may halt the spread of West Nile Virus (WNV) among common and endangered bird species. WNV, a mosquito borne pathogen, arrived in North America in 1999 and is now endemic across the continent. In 2012 alone, WNV killed 286 people in the United States, and 42 people have died from the virus in Canada since 2002. There is currently no effective vaccine against WNV infection in humans or birds. Common birds such as crows, ravens and jays, and endangered species such as the Greater Sage-Grouse and ...

Double-barreled attack on obesity in no way a no-brainer

2013-07-09

In the constant cross talk between our brain and our gut, two gut hormones are already known to tell the brain when we have had enough to eat. New research suggests that boosting levels of these hormones simultaneously may be an effective new weapon in the fight against obesity. Dr Shu Lin, Dr Yan-Chuan Shi and Professor Herbert Herzog, from Sydney's Garvan Institute of Medical Research, have shown that when mice are injected with PYY3-36 and PP, they eat less, gain less fat, and tend not to develop insulin-resistance, a precursor to diabetes. At the same time, the researchers ...

Graphene on its way to conquer Silicon Valley

2013-07-09

The unique properties of graphene such as its incredible strength and, at the same time, its little weight have raised high expectations in modern material science. Graphene, a two-dimensional crystal of carbon atoms packed in a honeycomb structure, has been in the focus of intensive research which led to a Nobel Prize of Physics in 2010. One major challenge is to successfully integrate graphene into the established metal-silicide technology. Scientists from the University of Vienna and their co-workers from research institutes in Germany and Russia have succeeded in fabricating ...

Technologies for monitoring remaining leukemia after treatment may help predict patient outcomes

2013-07-09

(WASHINGTON, July 9, 2013) – New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL). Study results were published online today in Blood, the Journal of the American Society of Hematology (ASH). Approximately 25 to 30 percent of all adults with ALL, the second most common type of acute leukemia, have what is known as Philadelphia ...

Are clinical trial data shared sufficiently today?

2013-07-09

Ben Goldacre, research fellow at the London School of Hygiene and Tropical Medicine, says we need all the evidence to make informed decisions about medicines. The lack of progress on transparency has been startling, he writes. Current estimates suggest that around half of all trials for the treatments being used today have gone unpublished; and that trials with positive results are twice as likely to be published. There is legislation mandating greater transparency – such as the law requiring trial results to be posted on the website clinicaltrials.gov – but the published ...

Suspicions confirmed: Brain tumors in children have a common cause

2013-07-09

Brain cancer is the primary cause of cancer mortality in children. Even in cases when the cancer is cured, young patients suffer from the stress of a treatment that can be harmful to the developing brain. In a search for new target structures that would create more gentle treatments, cancer researchers are systematically analyzing all alterations in the genetic material of these tumors. This is the mission of the PedBrain consortium, which was launched in 2010. Led by Professor Stefan Pfister from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), ...

LAST 30 PRESS RELEASES:

SNU researchers develop world’s first technology to observe atomic structural changes of nanoparticles in 3D

SNU researchers develop a new synthesis technology of single crystal 2D semiconductors, “Hypotaxy,” to enhance the commercialization of next-generation 2D semiconductors